Melanotan II Spray
A cyclic heptapeptide analog of alpha-MSH that binds melanocortin receptors (MC1R-MC5R), studied for melanogenesis pathways in research settings. Premium Research Peptide.
$59.99
|
15MG
|
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.
Certificate of Analysis
Purity by HPLC
| Parameter | Result | Specification |
|---|---|---|
| Appearance | Good | Meets spec |
| Purity | 99.83% · Pass | ≥ 95% |
| Net Peptide Content | 10.48mg | Report |
| Identity | Confirmed | Meets spec |
| Fentanyl Screen | Not Detected | Pass |
| Heavy Metals | Not Detected | Pass |
| Sterility | No Growth | Pass |
| Endotoxin | < 0.05 EU/mL | Reported |
Representative report from lot MII0002 (Melanotan II Spray). Your order ships with its own lot-specific certificate.
View this batch's certificateThird-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Compound Information
Chemical and structural properties
Melanotan II Structure
Synthetic cyclic heptapeptide analog of α-MSH
Melanocortin Receptor Affinity
Non-selective melanocortin receptor agonist
Handling & Storage
Supplied ready to use. No reconstitution required.
Sources & References
Peer-reviewed research
A randomized controlled trial of melanotan II in the induction of eumelanin synthesis in fair-skinned subjects
Barnetson RS, et al.
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study
Wessells H, et al.
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study
Dorr RT, et al.
Discovery and development of novel melanogenic drugs. Melanotan-I and -II
Hadley ME, Dorr RT
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist
Diamond LE, et al.
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.